Atlas Trials

Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI

Clinical trial NCT05511116 · UNKNOWN

Trial details

NCT number
NCT05511116
Sponsor
Fondation Hôpital Saint-Joseph
Status
UNKNOWN
Study type
OBSERVATIONAL
Pancreas CancerAdenocarcinoma
Start date
2022-07-18
Primary completion
2022-08-18
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.